The DOI matches its Crossref record.
Randomised controlled trial of enalapril and β blockers in non- diabetic chronic renal failure
Open accessAbstract
Objective : To compare the ability of angiotensin converting enzyme inhibitors and β blockers to slow the development of end stage renal failure in non-diabetic patients with chronic renal failure. Design : Open randomised multicentre trial with three year follow up. Setting : Outpatient departments of six French hospitals. Patients : 100 hypertensive patients with chronic renal failure (initial serum creatinine 200-400 μmol/l). 52 randomised to enalapril and 48 to β blockers (conventional treatment). Interventions : Enalapril or β blocker was combined with frusemide and, if necessary, a calcium blocker or centrally acting drug in patients whose diastolic pressure remained above 90 mm Hg. Results : 17 patients receiving conventional treatment and 10 receiving enalapril developed end stage renal failure. The cumulative renal survival rate was significantly better in the enalapril group than in the conventional group (P<0.05). The slope of the reciprocal serum creatinine concentration was steeper in the conventionally treated patients (- 6.89x10 -5 l/μmol/month) than in the enalapril group (-4.17x10 -5 l/μmol/month; P<0.05). No difference in blood pressure was found between groups. Conclusion : In hypertensive patients with chronic renal failure enalapril slows progression towards end stage renal failure compared with β blockers. This effect was probably not mediated through controlling blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452
Jafar, T. H., Schmid, C. H., Landa, M., Giatras, I., Toto, R., Remuzzi, G., Maschio, G., Brenner, B. M., Kamper, A., Zucchelli, P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-2-200107170-00007 · Cited by 1,092
Self-citationBakris, G. L., & Weir, M. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.685 · Cited by 823
Metadata
- Authors
- Hannedouche, T., Landais, P., Goldfarb, B., Esper, N. E., Fournier, A., Godin, M., Durand, D., Chanard, J., Mignon, F., Suc, J.-M., & Grunfeld, J.-P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1994-10-01
- Volume
- 309
- Issue
- 6958
- Pages
- 833-837
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2087709498
- Cited by
- 220
- References
- 0
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomised controlled trial of enalapril and β blockers in non- diabetic chronic renal failure. https://app.cochat.ai/papers/10.1136/bmj.309.6958.833
- The paper
- Hannedouche, T., Landais, P., Goldfarb, B., Esper, N. E., Fournier, A., Godin, M., Durand, D., Chanard, J., Mignon, F., Suc, J.-M., & Grunfeld, J.-P. (1994). Randomised controlled trial of enalapril and β blockers in non- diabetic chronic renal failure. BMJ. https://doi.org/10.1136/bmj.309.6958.833
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.